These results demonstrated that circNEIL3 enhanced the stability of IGF2BP3 protein by inhibiting ubiquitin/proteasome-dependent degradation, thereby promoting malignant progression of glioma. The gene discussed is IGF2BP3; the disease is central nervous system cancer.